Qiagen N.V. (QGEN)
| Previous close | 41.08 |
| Open | 41.10 |
| Bid | 41.41 x 800 |
| Ask | 41.44 x 800 |
| Day's range | 41.07 - 41.56 |
| 52-week range | 34.74 - 47.70 |
| Volume | |
| Avg. volume | 1,022,401 |
| Market cap | 9.175B |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | 27.27 |
| EPS (TTM) | 1.52 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | 1.28 (2.94%) |
| Ex-dividend date | 30 Jan 2024 |
| 1y target est | 50.98 |
Insider Monkey7 Best Sites Like Ancestry.com to Research Your Family History
In this article, we take a look at 7 best sites like Ancestry.com to research your family history. If you would like to skip our detailed analysis of the genealogy industry, you can directly go to 3 Best Sites Like Ancestry.com to Research Your Family History. The Genealogy Industry Genealogy is the study of families, […]
GlobeNewswireQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control // Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB management and control amid globally rising incidence ratesVenlo, the Netherla
ZacksUnveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Qiagen (QGEN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
